利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

46 条记录 (耗时 0.05 秒)

    Car cup holder
    2.
    外观设计
    Car cup holder 有权

    公开(公告)号：USD1027570S1

    公开(公告)日：2024-05-21

    申请号：US29888260

    申请日：2023-03-29

    申请人： Weijiang Zhang

    设计人： Weijiang Zhang

    摘要： FIG. 1 is a front, left and top perspective view of a car cup holder, showing my new design;
    FIG. 2 is a rear, right and bottom perspective view thereof;
    FIG. 3 is a front and top perspective view of the car cup holder in a use state;
    FIG. 4 is a rear and bottom perspective view of the car cup holder in a use state;
    FIG. 5 is a front view of the car cup holder of FIGS. 1 and 2;
    FIG. 6 is a rear view thereof;
    FIG. 7 is a left side view thereof;
    FIG. 8 is a right side view thereof;
    FIG. 9 is a top plan view thereof; and,
    FIG. 10 is a bottom plan view thereof.

    Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
    4.
    发明授权
    Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds 有权
    取代的4-氨基-1-（吡啶基甲基）哌啶及相关化合物

    公开(公告)号：US08030502B2

    公开(公告)日：2011-10-04

    申请号：US11974982

    申请日：2007-10-17

    申请人： Mathai Mammen ,  David Oare ,  Junning Lee ,  Weijiang Zhang

    发明人： Mathai Mammen ,  David Oare ,  Junning Lee ,  Weijiang Zhang

    IPC分类号： C07D207/08

    CPC分类号： C07D401/14

    摘要： This invention provides 4-amino-1-(pyridylmethyl)piperidine and related compounds and pharmaceutically acceptable salts thereof which are useful as muscarinic receptor antagonists. This invention also provides pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors, such as overactive bladder, irritable bowel syndrome and chronic obstructive pulmonary disease, using such compounds.

    摘要翻译： 本发明提供了可用作毒蕈碱受体拮抗剂的4-氨基-1-（吡啶基甲基）哌啶及其相关化合物及其药学上可接受的盐。 本发明还提供含有这些化合物的药物组合物; 用于制备这些化合物的方法和中间体; 以及使用这些化合物治疗由毒蕈碱受体介导的疾病状况的方法，例如膀胱过度活动，肠易激综合征和慢性阻塞性肺疾病。

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
    8.
    发明授权
    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid 有权
    烷氧基咪唑-1-基甲基联苯羧酸的结晶形式

    公开(公告)号：US08455530B2

    公开(公告)日：2013-06-04

    申请号：US13411319

    申请日：2012-03-02

    申请人： Robert S. Chao ,  Weijiang Zhang

    发明人： Robert S. Chao ,  Weijiang Zhang

    IPC分类号： A61K31/415 ,  C07D233/54

    CPC分类号： C07D233/70

    摘要： The invention provides a crystalline freebase form of 4′-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]imidazol-1-ylmethyl}-3′-fluorobiphenyl-2-carboxylic acid. This invention also provides pharmaceutical compositions comprising the crystalline compound, processes and intermediates for preparing the crystalline compound, and methods of using the crystalline compound to treat diseases such as hypertension.

    摘要翻译： 本发明提供了4' - {2-乙氧基-4-乙基-5 - [（（S）-2-巯基-4-甲基戊酰氨基）甲基]咪唑-1-基甲基} -3'-氟联苯基 - 吡啶-2-羧酸。 本发明还提供了包含结晶化合物的药物组合物，用于制备结晶化合物的方法和中间体，以及使用结晶化合物治疗高血压疾病的方法。